- News & Analysis
- Home
- Latest News
- Reports
- Podcasts
- The CVC Funding Round Database
- The CVC Directory
- University
- Video
- Subscribe
- Newsletters
- Job Postings
- Events
Global University Venturing
ApoGen applies itself to $7m series A
Washington Research Foundation and Arch Venture Partners are among the investors in the genomic cancer treatment spinout of University of Minnesota.
Dec 14, 2016BlueRock Therapeutics generates $225m series A
Bayer Lifescience Center joined Versant Ventures to launch BlueRock, a Kyoto spinout that will develop stem cell treatments for cardiovascular diseases and neurodegenerative disorders.
Dec 13, 2016Cell Design Labs engineers $34m round
The biotherapeutics developer, a UCSF spinout, raised funds from backers like cancer immunotherapy developer Kite Pharma, a UCLA spinout.
Dec 12, 2016Universidade Nova de Lisboa takes a trip to Frontier IP
The IP investment firm, which advises universities on spinouts in exchange for equity stakes, has signed its second deal in Portugal.
Dec 12, 2016PsiOxus partners Bristol-Myers to treat late-stage cancer
The Imperial Innovations-backed cancer treatment developer secured $10m from Bristol-Myers to test two drugs to be used in combination.
Dec 12, 2016Big deal: OSI grows to $730m
University venturing fund Oxford Sciences Innovation has added an additional $290m to its assets as spinout Oxford Nanopore attracts another $126m in funding.
Dec 12, 2016Oxford Nanopore sequences $126m investment
The spinout has raised additional funding after announcing earlier this month that it had become the first company to sequence multiple human genomes using portable technology.
Dec 12, 2016Enterprise Therapeutics breathes easy with $5m
Sussex spinout Enterprise Therapeutics, a developer of treatments for respiratory diseases, has secured capital from return investor Imperial Innovations.
Dec 12, 2016Global Brain dreams up $175m fund
Several universities are among the limited partners for the venture firm's latest fund, which is expected to close at $175m.
Dec 12, 2016Vesper sounds out corporates for $15m series A
Michigan spinout Vesper's investors include Amazon's Alexa Fund, AAC Technologies, Mirae Nano Tech and XinGang Electronics.
Dec 12, 2016Featured Content
University Venture Funds: The ListThe definitive list of university venture funds around the worldUniversity Venture Funds: The List
The definitive list of university venture funds around the world
Special ReportCorporate collaboration with universities: How to commercialise innovative researchSpecial Report
Corporate collaboration with universities: How to commercialise innovative research
Beyond the Breakthrough PodcastExplore the BTB podcast archive with the world's brightest minds in university innovation answering the question: how does research make it from a lab into the real world?Beyond the Breakthrough Podcast
Explore the BTB podcast archive with the world's brightest minds in university innovation answering the question: how does research make it from a lab into the real world?
About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits our membership, providing privileged access to all our services and resources.
Navigation
